Cargando…
ITGB1-DT/ARNTL2 axis may be a novel biomarker in lung adenocarcinoma: a bioinformatics analysis and experimental validation
BACKGROUND: Lung cancer is one of the most lethal malignant tumors that endangers human health. Lung adenocarcinoma (LUAD) has increased dramatically in recent decades, accounting for nearly 40% of all lung cancer cases. Increasing evidence points to the importance of the competitive endogenous RNA...
Autores principales: | Qiu, Bai-Quan, Lin, Xia-Hui, Lai, Song-Qing, Lu, Feng, Lin, Kun, Long, Xiang, Zhu, Shu-Qiang, Zou, Hua-Xi, Xu, Jian-Jun, Liu, Ji-Chun, Wu, Yong-Bing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670189/ https://www.ncbi.nlm.nih.gov/pubmed/34906142 http://dx.doi.org/10.1186/s12935-021-02380-2 |
Ejemplares similares
-
Upregulation of ARNTL2 is associated with poor survival and immune infiltration in clear cell renal cell carcinoma
por: Wang, Song, et al.
Publicado: (2021) -
ITGB1-DT Facilitates Lung Adenocarcinoma Progression via Forming a Positive Feedback Loop With ITGB1/Wnt/β-Catenin/MYC
por: Chang, Ruimin, et al.
Publicado: (2021) -
The prognostic value of ITGA and ITGB superfamily members in patients with high grade serous ovarian cancer
por: Zhu, Tingting, et al.
Publicado: (2020) -
Bioinformatics analysis combined with experiments predicts CENPK as a potential prognostic factor for lung adenocarcinoma
por: Ma, Jiayu, et al.
Publicado: (2021) -
Six immune-related promising biomarkers may promote hepatocellular carcinoma prognosis: a bioinformatics analysis and experimental validation
por: Lin, Xia-Hui, et al.
Publicado: (2023)